Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
First Community Corp
FCCO
$306M
| $933K | ﹤0.01% |
28,548
+5,927
| +26% | +$182K |
2025 Q2
4 quarters
|
|
3027
Verastem
VSTM
$747M
| $932K | ﹤0.01% |
243,950
+47,449
| +24% | +$230K |
2024 Q1
9 quarters
|
|
3028
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$148M
| $928K | ﹤0.01% |
296,643
-76,888
| -21% | -$257K |
2018 Q3
31 quarters
|
|
3029
Century Therapeutics
IPSC
$261M
| $928K | ﹤0.01% |
378,867
+299,452
| +377% | +$684K |
2026 Q1
1 quarter
|
|
3030
Lightbridge
LTBR
$202M
| $923K | ﹤0.01% |
105,016
+19,160
| +22% | +$216K |
2025 Q2
4 quarters
|
|
3031
Lands' End
LE
$310M
| $922K | ﹤0.01% |
87,936
-7,456
| -8% | -$85.7K |
2014 Q2
48 quarters
|
|
3032
Palisade Bio
PALI
$277M
| $909K | ﹤0.01% |
434,983
+358,983
| +472% | +$707K |
2026 Q1
1 quarter
|
|
3033
Crescent Biopharma
CBIO
$537M
| $905K | ﹤0.01% |
+50,258
| New | +$981K |
2026 Q2
0 quarters
|
|
3034
Citi Trends
CTRN
$407M
| $902K | ﹤0.01% |
15,595
+1,730
| +12% | +$82.9K |
2013 Q2
52 quarters
|
|
3035
Aura Minerals Inc
AUGO
$7.7B
| $898K | ﹤0.01% |
+14,260
| New | +$1.12M |
2026 Q2
0 quarters
|
|
3036
Tenax Therapeutics
TENX
$68.5M
| $890K | ﹤0.01% |
+61,174
| New | +$781K |
2026 Q2
0 quarters
|
|
3037
MacroGenics
MGNX
$237M
| $890K | ﹤0.01% |
192,635
+152,584
| +381% | +$577K |
2026 Q1
1 quarter
|
|
3038
Velo3D Inc
VELO
$257M
| $881K | ﹤0.01% |
50,207
+40,206
| +402% | +$697K |
2026 Q1
1 quarter
|
|
3039
VanEck Long Muni ETF
MLN
$667M
| $878K | ﹤0.01% |
49,380
+15,255
| +45% | +$268K |
2025 Q3
3 quarters
|
|
3040
LoveSac
LOVE
$210M
| $876K | ﹤0.01% |
52,478
+5,568
| +12% | +$88K |
2018 Q4
30 quarters
|
|
3041
Mistras Group
MG
$658M
| $876K | ﹤0.01% |
50,134
+18,994
| +61% | +$338K |
2023 Q2
12 quarters
|
|
3042
OppFi
OPFI
$496M
| $868K | ﹤0.01% |
87,450
+13,145
| +18% | +$114K |
2022 Q2
16 quarters
|
|
3043
Nathan's Famous
NATH
$417M
| $866K | ﹤0.01% |
8,527
+865
| +11% | +$87.5K |
2023 Q2
12 quarters
|
|
3044
TechTarget
TTGT
$278M
| $866K | ﹤0.01% |
240,535
+6,756
| +3% | +$31K |
2013 Q2
52 quarters
|
|
3045
Venu Holding Corp
VENU
$68.9M
| $862K | ﹤0.01% |
379,625
+229,147
| +152% | +$820K |
2025 Q3
3 quarters
|
|
3046
Avidbank Holdings
AVBH
$343M
| $857K | ﹤0.01% |
25,951
+16,405
| +172% | +$500K |
2025 Q4
2 quarters
|
|
3047
Rocky Brands
RCKY
$343M
| $850K | ﹤0.01% |
20,618
+2,038
| +11% | +$79.6K |
2018 Q2
32 quarters
|
|
3048
Boston Omaha
BOC
$384M
| $848K | ﹤0.01% |
62,181
+6,347
| +11% | +$79.9K |
2018 Q3
31 quarters
|
|
3049
SharonAI Holdings
SHAZ
$1.28B
| $842K | ﹤0.01% |
+9,945
| New | +$561K |
2026 Q2
0 quarters
|
|
3050
Gemini Space Station
GEMI
$533M
| $842K | ﹤0.01% |
197,606
+98,900
| +100% | +$466K |
2025 Q4
2 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.